EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Opioid prescribing trends and pain scores among adult patients with cancer in a large health system

Laura Van Metre Baum iD, Pamela R Soulos, Madhav Kc, Molly M Jeffery, Kathryn J Ruddy iD, Catherine C Lerro, Hana Lee, David J Graham, Donna R Rivera, Mark Liberatore, Michael S Leapman iD, Vikram Jairam und 3 weitere

Cancer · 2025

DOI: 10.1002/cncr.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Laura Van Metre Baum und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Practice Patterns, Physicians', Neoplasms, Cancer Pain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: US Food and Drug Administration, U.S. Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Opioid stewardship policies could adversely affect pain management for patients with cancer. Yet patients with cancer are also at risk for opioid‐related harms. This study sought to determine trends in opioid prescribing by clinical stratum and pain for patients with cancer from 2016 to 2020.

Methods

A retrospective study was conducted of opioid‐naive adults with newly diagnosed cancer from 2016 to 2020 ( N = 10,232) in a large Connecticut health system. Logistic regression was used to calculate changes in the predicted probability of opioid prescribing from 2016 to 2020. Two subpopulations were examined: patients treated surgically ( n = 4405) and patients with metastatic cancer ( n = 2158). Flowsheet pain scores for patients with metastatic cancer were used to stratify by no pain (all scores, 0) versus any pain. The main outcomes were new (≥1 prescription in the 0–6 months after diagnosis) and additional (0–6 and 7–9 months) opioid prescriptions.

Results

A decline was observed in the predicted probability of new (71.1% to 64.6%; p < .001) and additional prescribing (27.2% to 24.2%; p = .07 [not significant]) declined. Among surgical patients, the predicted probability of new opioid prescribing fell (96.0% to 88.6%; p < .001), whereas additional prescribing was stable (13%). For patients with metastatic cancer with pain, new opioid prescribing was stable (56%). For those reporting no pain, the predicted probability of new opioid prescribing declined from 61.6% to 36.1% ( p < .001).

Conclusions

In the context of widespread policy changes, this study showed a modest decline in new and additional opioid prescribing for patients with cancer. In metastatic cancer, prescribing remained stable for patients reporting pain and declined steeply for those reporting no pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidPractice Patterns, Physicians'NeoplasmsCancer PainPain ManagementDrug PrescriptionsHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedConnecticutPain Measurement

Stichwörter der Autor:innen

Connecticutcancer survivorshipcancer‐related painopioid epidemicopioid prescribingpain managementpostoperative painretrospective study

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Laura Van Metre Baum, Kathryn J Ruddy, Michael S Leapman, Cary P Gross, Henry S Park

Förderung

  • US Food and Drug Administration
  • U.S. Food and Drug Administration

Zitieren

APA

Baum, L. V. M., Soulos, P. R., Kc, M., Jeffery, M. M., Ruddy, K. J., Lerro, C. C., Lee, H., Graham, D. J., Rivera, D. R., Liberatore, M., Leapman, M. S., Jairam, V., Dinan, M. A., Gross, C. P., & Park, H. S. (2025). Opioid prescribing trends and pain scores among adult patients with cancer in a large health system. Cancer. https://doi.org/10.1002/cncr.70027

Vancouver

Baum LVM, Soulos PR, Kc M, Jeffery MM, Ruddy KJ, Lerro CC, et al. Opioid prescribing trends and pain scores among adult patients with cancer in a large health system. Cancer. 2025. doi:10.1002/cncr.70027

BibTeX
@article{Baum2025,
  author = {Baum, Laura Van Metre and Soulos, Pamela R and Kc, Madhav and Jeffery, Molly M and Ruddy, Kathryn J and Lerro, Catherine C and Lee, Hana and Graham, David J and Rivera, Donna R and Liberatore, Mark and Leapman, Michael S and Jairam, Vikram and Dinan, Michaela A and Gross, Cary P and Park, Henry S},
  title = {Opioid prescribing trends and pain scores among adult patients with cancer in a large health system},
  journal = {Cancer},
  year = {2025},
  doi = {10.1002/cncr.70027}
}
Kostenlos starten →